Search Results For :: empty capsules

• Sorbitol Market by Product Type (Liquid/Syrup Sorbitol, and Crystal/Powder Sorbitol), Application (Cosmetics & Personal Care, Food & Beverage, Pharmaceuticals, Chemicals), and Region - Global Forecast to 2021

  The market size of sorbitol is projected to grow from USD 1.09 Billion in 2016 to USD 1.42 Billion by 2021, at a CAGR of 5.3% from 2016 to 2021. Globally, people are diagnosed with diabetes; most of them are reported to be affected with type 2 diabetes. Type 2 diabetes is associated with food consumption habits and obesity.

  • Published: March 2017
  • Price: $ 4950
  • TOC Available:

• Probiotics Market Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel, and Region - Global Forecast to 2030

  The global probiotics market is estimated to be valued at USD 76.59 billion in 2025 and is projected to reach USD 114.95 billion by 2030, growing at a CAGR of 8.5% from 2025 to 2030. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).

  • Published: March 2026
  • Price: $ 4950
  • TOC Available:

• World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015

  The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.

  • Published: August 2011
  • Price: $ 4950
  • TOC Available:

• Global Ophthalmology Drugs & Devices Market

  Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.

  • Published: May 2010
  • Price: $ 4950
  • TOC Available:

• Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031

  The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%. The key players include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

  • Published: July 2026
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 21 to 25 of 25